NOVARTIS AG (NVSEF)
Clinical trial NCT01797523 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-10-31 → 2026-02-04 3. primary completion date: 2027-10-31 → 2026-02-04
Clinical trial NCT01797523 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-10-31 → 2026-02-04 3. primary completion date: 2027-10-31 → 2026-02-04
📉 **NEGATIVE** • Medium confidence analysis (61%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (25%) **Content type:** Clinical